Parkinson's Trial NCT07028515
Improve upper limb motor learning
- Trial ID
- NCT07028515
- Official Title
- Effects of Self-controlled Practice on Motor Learning and Motivation in People With Parkinson's Disease
- Goal
- Improve upper limb motor learning
- Status
- RECRUITING
- Sponsor
- National Taiwan University Hospital
- Study Type
- OBSERVATIONAL
- Enrollment
- 72 participants
- Conditions
- Parkinson Disease
Summary For Families
They want to find out whether letting people with Parkinson's choose key parts of their practice helps them learn a new arm/hand movement better and stay more motivated. Participants will perform a motor task where they can control things like when to attempt a movement or how many repetitions they do, while researchers measure improvements and motivation, on the theory that choice boosts attention, confidence, and skill retention without changing medications. People 20 and older with Parkinson's who can follow task instructions and have no recent upper limb surgery or injury can join, while those with other neurological disorders, severe upper-limb tremor, significant anxiety or depression, implanted DBS or pacemaker, seizure history, unstable medical issues, uncontrolled migraines or tinnitus, or pregnancy are excluded.
Locations
- School and Graduate Institute of Physical Therapy, Taipei, Zhongzheng Dist., Taiwan
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. They want to find out whether letting people with Parkinson's choose key parts of their practice helps them learn a new arm/hand movement better and stay more motivated. Participants will perform a motor task where they can control things like when to attempt a movement or how many repetitions they do, while researchers measure improvements and motivation, on the theory that choice boosts attention, confidence, and skill retention without changing medications. People 20 and older with Parkinson's who can follow task instructions and have no recent upper limb surgery or injury can join, while those with other neurological disorders, severe upper-limb tremor, significant anxiety or depression, implanted DBS or pacemaker, seizure history, unstable medical issues, uncontrolled migraines or tinnitus, or pregnancy are excluded.
- Who can participate?
- Participants must be at least 20 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 2 years.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.
- How many visits does this trial involve?
- You will need to visit the lab three times in one week (Day 1, Day 2, and Day 7).